New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists
复制标题
DOI:
10.1136/ard.2005.037424
复制
发表时间:
2006-03-01
影响因子:
27.4
通讯作者:
Burmester, GR
中科院分区:
文献类型:
--
作者:
Kary, S;Worm, M;Burmester, GR
Background: Blockage of tumour necrosis factor alpha (TNF alpha) is highly effective in rheumatic diseases, especially in rheumatoid arthritis (RA), ankylosing spondylitis, and psoriatic arthritis. Furthermore, TNF alpha antagonists have also been shown to significantly reduce psoriatic skin lesions.Case reports: A series of nine patients with RA who were treated with different types of TNF alpha antagonists and who unexpectedly developed either a new onset or an exacerbation of psoriatic skin lesions are reported.